Literature DB >> 6753772

One-lung high-frequency ventilation for tracheoplasty and bronchoplasty: a new technique.

N El-Baz, R Jensik, L P Faber, R S Faro.   

Abstract

Major airway surgery requires the maintenance of adequate ventilation and oxygenation during the period of resection and reconstruction, as well as an unobstructed surgical field and optimal access to the airway's circumference. High-frequency positive-pressure ventilation (HFPPV) at a frequency of 1 Hz (60 breaths/min) or more, along with a small tidal volume (50 to 250 cc), provides adequate ventilation and oxygenation with minimal impairment of pulmonic and systemic circulatory functions. We have used HFPPV of one lung through a 2 mm internal diameter catheter in six patients (three undergoing right sleeve pneumonectomies, two having carinal tumor resections, and one having tracheal resection). High-frequency positive-pressure ventilation of the left lung provided continuous and adequate ventilation and oxygenation during the period of resection and reconstruction of the airways, while the small catheter permitted unimpaired visualization and adequate access to the operative site.

Entities:  

Mesh:

Year:  1982        PMID: 6753772     DOI: 10.1016/s0003-4975(10)63004-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  High frequency jet ventilation of one lung using a bronchial blocker of Univent during carinal resection.

Authors:  Ji Hyun Chin; Eun Ho Lee; Dae Kee Choi; In Cheol Choi
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

2.  Carinal resection with two high-frequency jet ventilation delivery systems.

Authors:  E R Perera; D M Vidic; J Zivot
Journal:  Can J Anaesth       Date:  1993-01       Impact factor: 5.063

3.  Ventilation catheter-assisted airway stenting under local anaesthesia for patients with airway stenosis: initial clinical experience.

Authors:  Ning Wei; Yu-Fei Fu; Ke Zhang; Hao-Guang Wan; Hao Xu
Journal:  Radiol Med       Date:  2014-08-05       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.